Comparative studies on behavioral neurochemical effects of N,α-diethylphenethylamine and methamphetamine in rats

Springer Science and Business Media LLC - Tập 33 - Trang 77-83 - 2014
Ilung Seol1, Dongkoo Lim2, Jaesin Lee3, Heejin Yang1
1National Forensic Service, Gwangju Institute, Jangseong, Republic of Korea
2College of Pharmacy, Chonnam National University, Gwangju, Republic of Korea
3National Forensic Service, Wonju, Republic of Korea

Tóm tắt

One objective was to compare the psychostimulating effects of N,α-diethylphenethylamine (NADEP) with those of methamphetamine (METH) in experiments on behavioral activities of rats. Another objective was to compare concentrations of neurotransmitters dopamine (DA), serotonin (5-HT), and their metabolites such as dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and 5-hydroxyindoleacetic acid (5-HIAA) in brain tissues (striatum and frontal cortex) carried out after administration of NADEP and METH in rats. The animals were treated with NADEP and METH for 6 consecutive days (5 mg/kg per day, respectively), and the scores of stereotypy were measured on the first, second, fourth, and sixth day. The increase of the stereotypy score was observed in the NADEP-treated group, but it was less than that after treatment with METH. NADEP administration (5 and 10 mg/kg) resulted in a significant increase of DA and 5-HT and a decrease of DOPAC and HVA in the striatum tissues, which were collected 1 h after administration, but the changes of the compounds were less than those after treatment with METH (5 mg/kg). Unlike the METH-treated group, the changed DA, 5-HT, DOPAC, and HVA levels of the NADEP- treated group (5 and 10 mg/kg) were soon recovered within 6 h after administration. Both NADEP and METH had no significant effect on the 5-HIAA concentrations of the brain tissues. These results suggest that NADEP has significant psychostimulatory effects, though the effects were less than those of METH. Thus, NADEP should be carefully monitored to avoid abuse as a psychoactive drug.

Tài liệu tham khảo

Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406–433 Moore KE (1977) The actions of amphetamine on neurotransmitters: a brief review. Biol Psychiatry 12:451–462 Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA, Price JL, Mathis CA (2001) Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49:81–96 Kuczenski R, Segal DS (1997) Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 68:2032–2037 Abekawa T, Ohmori T, Koyama T (1994) Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res 643:276–281 Brown JM, Riddle EL, Sandoval V, Weston RK, Hanson JE, Crosby MJ, Ugarte YV, Gibb JW, Hanson GR, Fleckenstein AE (2002) A single methamphetamine administration rapidly decreases vesicular dopamine uptake. J Pharmacol Exp Ther 302:497–501 Fleckenstein AE, Hanson GR (2003) Impact of psychostimulants on vesicular monoamine transporter function. Eur J Pharmacol 479:283–289 Scorza MC, Carrau C, Silveira R, Zapata-Torres G, Cassels BK, Reyes-Parada M (1997) Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives: structure-activity relationships. Biochem Pharmacol 54:1361–1369 Hilber B, Scholze P, Dorostkar MM, Sandtner W, Holy M, Boehm S, Singer EA, Sitte HH (2005) Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines. Neuropharmacology 49:811–819 Jones S, Kauer JA (1999) Amphetamine depresses excitatory synaptic transmission via serotonin receptors in the ventral tegmental area. J Neurosci 19:9780–9787 Higgins GA, Fletcher PJ (2003) Serotonin and drug reward: focus on 5-HT2C receptors. Eur J Pharmacol 480:151–162 József K, Antal S, Éva S, Zoltán T, Károly M, János B (1988) New psychostimulant agent. International application published under the patent cooperation treaty (PCT) by World Intellectual Property Organization (WIPO). Publication No. WO 88/02254 Noggle FT, Clark CR, Pitts-Monk P, De Ruiter J (1991) Liquid chromatographic and mass spectral analysis of 1-phenyl-2-butanamines: homologues of the amphetamines. J Liquid Chromatogr 14:1393–1408 Lee J, Choe S, Choi H, Heo S, Kim E, Kim H, Bang E, Chung H (2013) Identification of N-ethyl-α-ethylphenethylamine in crystalline powder seized for suspected drug trafficking: a research chemical or a new designer drug? Forensic Toxicol 31:54–58 Cohen PA, Travis JC, Venhuis BJ (2014) A methamphetamine analog (N,α-diethyl-phenethylamine) identified in a mainstream dietary supplement. Drug Test Anal 6:805–807 Lee J, Venhuis BJ, Heo S, Choi H, Seol I, Kim E (2014) Identification and quantitation of N,α-diethylphenethylamine in preworkout supplements sold via the Internet. Forensic Toxicol 32:148–153 Young A (2013) Popular sports supplements contain meth-like compound. USA TODAY 25 October 2013 Parliament of the United Kingdom (1971) Misuse of drugs act 1971 Junet R (1956) Ethylamphetamine in the treatment of obesity (in French). Praxis 45:986–988 Nichols DE (1986) Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. J Psychoact Drugs 18:305–313 Oberlender R, Nichols DE (1991) Structural variation and (+)-amphetamine like discriminative stimulus properties. Pharmacol Biochem Behav 38:581–586 Ricaurte GA, De Lanney LE, Irwin I, Witkin JM, Katz J, Langston JW (1989) Evaluation of the neurotoxic potential of N, N-dimethylamphetamine: an illicit analog of methamphetamine. Brain Res 490:301–306 Naylor RJ, Olley JE (1972) Modification of the behavioral changes induced by amphetamine in the rat by lesions in the caudate nucleus, the caudate-putamen and globus pallidus. Neuropharmacology 11:91–99 Kinnard WJ, Watzman N (1966) Techniques utilized in the evaluation of psychotropic drugs on animal activity. J Pharm Sci 55:995–1012 Schiørring E (1971) Amphetamine induced selective stimulation of certain behavior items with concurrent inhibition of others in an open-field test with rats. Behavior 39:1–17 Fibiger HC, Fibiger HP, Zis AP (1973) Attenuation of amphetamine-induced motor stimulation and stereotypy by 6-hydroxydopamine in the rat. Br J Pharmacol 47:683–692 Randrup A, Munkvad I (1967) Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia 11:300–310 Bedingfield JB, Calder LD, Thai DK, Karler R (1997) The role of the striatum in the mouse in behavioral sensitization to amphetamine. Pharmacol Biochem Behav 56:305–310 Bodybuilding.com (2014) CRAZE’s reviews on bodybuilding.com. http://reviews.bodybuilding.com/Driven_Sports/CRAZE/. Accessed 10 February 2014